Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer.

The retrospective study demonstrated tumor dose as being a highly significant factor in local disease control ( Table 1 ) and on a subsequent review of the patient cohort 10 years later, the group described the incidence of disabling complications as low and as expected related to total dose.

also in 132,142 other papers